Jailendra Singh analyst TRUIST

Currently out of the existing stock ratings of Jailendra Singh, 174 are a HOLD (46.28%), 11 are a SELL (2.93%), 191 are a BUY (50.8%).

Jailendra Singh

Work Performance Price Targets & Ratings Chart

Analyst Jailendra Singh, currently employed at TRUIST, carries an average stock price target met ratio of 53.11% that have a potential upside of 21.28% achieved within 138 days. Previously, Jailendra Singh worked at CREDIT SUISSE.

Jailendra Singh’s has documented 729 price targets and ratings displayed on 41 stocks. The coverage is on Healthcare, Financial Services, Consumer Defensive, Technology sectors.

Most recent stock forecast was given on PGNY, Progyny at 22-Jun-2026.

Wall Street Analyst Jailendra Singh

Analyst best performing recommendations are on OMI (OWENS & MINOR).
The best stock recommendation documented was for OMI (OWENS & MINOR) at 11/4/2020. The price target of $25 was fulfilled within 1 day with a profit of $1.16 (4.87%) receiving and performance score of 48.66.

Average potential price target upside

ABC AmerisourceBergen ACCD Accolade AMWL American Well Corp CLOV Clover Health Investments Corp GDRX Goodrx Holdings GOCO GoHealth HIMS Hims Hers Health MCK McKesson OMI Owens & Minor OSCR Oscar Health PRVA Privia Health Group TDOC Teladoc TLMD SOC Telemed TVTY Tivity Health EHTH eHealth CAH Cardinal Health CANO Cano Health ONEM 1Life Healthcare DH Definitive Healthcare Corp ONE OneSmart International Education Group CHNG Change Healthcare SLQT Selectquote AGL agilon health PINC Premier RCM R1 RCM DOCS Doximity IQV IQVIA Holdings NXGN Nextgen Healthcare PGNY Progyny ICLR ICON PLC VEEV Veeva Systems PHR Phreesia EVH Evolent Health MEDP Medpace Holdings ASTH Astrana Health FTRE Fortrea Holdings ON ON Semiconductor PI Impinj RC Ready Capital Corp TV Grupo Televisa SAB ADR LVGO Livongo Health

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Feb-2018

$215

$40.04 (22.89%)

$187

3 years 1 months 25 days ago
(07-Aug-2023)

15/16 (93.75%)

$28.91 (15.54%)

636

Hold Since 27-May-2022

$190

$15.04 (8.60%)

$176

3 years 1 months 29 days ago
(03-Aug-2023)

12/12 (100%)

$-0.86 (-0.45%)

392

Buy Since 11-Oct-2022

$215

$40.04 (22.89%)

$200

3 years 1 months 29 days ago
(03-Aug-2023)

7/10 (70%)

$24.14 (12.65%)

211

Buy Since 05-Aug-2021

$220

$45.04 (25.74%)

$213

3 years 1 months 29 days ago
(03-Aug-2023)

11/17 (64.71%)

$29.14 (15.27%)

326

$190

$15.04 (8.60%)

3 years 1 months 29 days ago
(03-Aug-2023)

9/9 (100%)

$-0.86 (-0.45%)

440

Show more analysts

Please expand the browser size to see the chart

Which stock is Jailendra Singh most bullish on?

Potential upside of $4.49 has been obtained for PGNY (PROGYNY)

Which stock is Jailendra Singh most reserved on?

Potential downside of -$10.94 has been obtained for HIMS (HIMS HERS HEALTH)

What Year was the first public recommendation made by Jailendra Singh?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?